Search Results - Hiroki Oe
- Showing 1 - 6 results of 6
-
1
Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial by Hiroki Oe, Kazufumi Nakamura, Hajime Kihara, Kenei Shimada, Shota Fukuda, Tsutomu Takagi, Toru Miyoshi, Kumiko Hirata, Junichi Yoshikawa, Hiroshi Ito
Published 2015Artigo -
2
Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report by Yoko Noda, Toru Miyoshi, Hiroki Oe, Yuko Ohno, Kazufumi Nakamura, Norihisa Toh, Kunihisa Kohno, Hiroshi Morita, Kengo Kusano, Hiroshi Ito
Published 2013Artigo -
3
Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats by Toru Miyoshi, Kazufumi Nakamura, Masashi Yoshida, Daiji Miura, Hiroki Oe, Satoshi Akagi, Hiroki Sugiyama, Kaoru Akazawa, Tomoko Yonezawa, Jun Wada, Hiroshi Ito
Published 2014Artigo -
4
Diagnostic Accuracy and Cost‐Effectiveness of a Pocket‐Sized Transthoracic Echocardiographic Imaging Device by Ryoko Kitada, Shota Fukuda, Hiroyuki Watanabe, Hiroki Oe, Yukio Abe, Minoru Yoshiyama, Jong‐Min Song, Marta Sitges, Takahiro Shiota, Hiroshi Ito, Junichi Yoshikawa
Published 2013Artigo -
5
DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study by Kazufumi Nakamura, Hiroki Oe, Hajime Kihara, Kenei Shimada, Shota Fukuda, Kyoko Watanabe, Tsutomu Takagi, Kei Yunoki, Toru Miyoshi, Kumiko Hirata, Jun–ichi Yoshikawa, Hiroshi Ito
Published 2014Artigo -
6
Beta-Blockers and Oxidative Stress in Patients with Heart Failure by Kazufumi Nakamura, Masato Murakami, Daiji Miura, Kei Yunoki, Kenki Enko, Masamichi Tanaka, Yukihiro Saito, Nobuhiro Nishii, Toru Miyoshi, Masashi Yoshida, Hiroki Oe, Norihisa Toh, Satoshi Nagase, Kunihisa Kohno, Hiroshi Morita, Hiromi Matsubara, Kengo Kusano, Tohru Ohe, Hiroshi Ito
Published 2011Revisão
Search Tools:
Related Subjects
Internal medicine
Medicine
Diabetes mellitus
Dipeptidyl peptidase-4 inhibitor
Endocrinology
Type 2 diabetes
Cardiology
Dipeptidyl peptidase-4
Blood pressure
Clinical endpoint
Endothelial dysfunction
Pharmacology
Pioglitazone
Postprandial
Sitagliptin
Type 2 Diabetes Mellitus
Adrenergic
Alogliptin
Angiology
Area under the curve
BETA (programming language)
Biochemistry
Brachial artery
Cardiac hypertrophy
Chemistry
Clinical Practice
Clinical trial
Computer science
Cost effectiveness
Diagnostic accuracy